Screener
Johnson & Johnson JNJ Income Statement
| Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | ||
|---|---|---|---|---|---|---|
| $25.31B+6.6% | $24.06B+9.9% | $24.56B+9.1% | $23.99B+6.8% | $23.74B+5.8% | ||
| $8.05B+5.5% | $8.11B+10.2% | $7.97B+11.8% | $7.3B+4.9% | $7.63B+11.0% | ||
| $17.26B+7.1% | $15.96B+9.8% | $16.6B+7.8% | $16.69B+7.6% | $16.12B+3.4% | ||
| 68.2%+0.3pp | 66.3%-0.1pp | 67.6%-0.8pp | 69.6%+0.5pp | 67.9%-1.5pp | ||
| $3.65B+3.9% | —— | $27.25M-94.1% | $27.25M-94.1% | $3.52B+664% | ||
| $6.43B+9.2% | $6.03B+18.0% | $6.75B+4.6% | $5.92B+8.1% | $5.89B+3.7% | ||
| $7.14B+7.4% | $6.33B+2.3% | $5.43B+51.5% | $7.03B+39.6% | $6.65B+5.9% | ||
| 28.2%+0.2pp | 26.3%-1.9pp | 22.1%+6.2pp | 29.3%+6.9pp | 28%0.0pp | ||
| $281M-8.8% | $272M+33.3% | $214M+56.2% | $245M+26.9% | $308M+14.1% | ||
| -$331M-209% | —— | —— | —— | -$107M— | ||
| $6.75B+3.9% | $5.99B-56.1% | $4.97B+27.8% | $7.49B+124% | $6.49B+12.9% | ||
| $1.21B+27.1% | $755M-71.3% | $0-100% | $2.34B+264% | $954M-10.2% | ||
| $5.53B-0.1% | $5.24B-52.4% | $5.12B+49.1% | $5.15B+91.2% | $5.54B+18.2% | ||
| 21.9%-1.5pp | 21.8%-28.5pp | 20.8%+5.6pp | 21.5%+9.5pp | 23.3%+2.4pp | ||
| $2.27-0.9% | $2.14-52.9% | $2.09+48.2% | $2.12+91.0% | $2.29+18.7% | ||
| $9.1B+5.9% | $8.33B+4.7% | $7.44B+35.8% | $8.81B+28.0% | $8.59B+6.6% | ||
| 36%-0.2pp | 34.6%-1.7pp | 30.3%+6.0pp | 36.7%+6.1pp | 36.2%+0.3pp | ||
| $7.14B+7.4% | $6.33B+2.3% | $5.43B+51.5% | $7.03B+39.6% | $6.65B+5.9% |
FAQ
- What is Johnson & Johnson's revenue?
- Johnson & Johnson (JNJ) generated $97.9B in revenue over the trailing twelve months, up 8.1% year over year.
- Is Johnson & Johnson profitable?
- Johnson & Johnson reported $21.0B in net income over the trailing twelve months, a 21.5% net margin.
- What are Johnson & Johnson's profit margins?
- Gross margin is 67.9% and operating margin is 26.5%, with a 21.5% net margin.
- What is Johnson & Johnson's earnings per share?
- Johnson & Johnson's diluted EPS over the trailing twelve months is $8.62.
- Where does Johnson & Johnson's income statement data come from?
- Every line is extracted from Johnson & Johnson's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
